IV ketamine for Palm Beach Gardens — psychiatry-supervised, integrated with therapy.

For Palm Beach Gardens residents — PGA National, Mirasol, BallenIsles, Frenchman's Reserve, Old Palm — RECO Health's Delray Beach campus is 25 miles south, roughly 35 minutes on I-95. IV ketamine at RECO is psychiatry-supervised: board-certified psychiatric evaluation, 0.5 mg/kg racemic ketamine infused over 40 minutes with continuous vital-sign monitoring and CADSS assessment, and a six-infusion induction paired with next-day integration therapy in ACT, EMDR, or CBT frames. Both IV ketamine and Spravato (esketamine) are offered in the same program, so the modality decision is a shared clinical judgment rather than a logistical constraint.

Palm Beach Gardens sits 25 miles north of RECO Health’s Delray Beach campus — roughly 35 minutes south on I-95. For residents of PGA National, Mirasol, BallenIsles, Frenchman’s Reserve, and Old Palm, that drive opens access to a psychiatry-supervised IV ketamine program integrated with therapy — a level of clinical density that northern Palm Beach County outpatient practices rarely deliver in-house.

Ketamine’s mechanism and why it works fast

Ketamine is a non-competitive NMDA receptor antagonist. Its antidepressant effect is not driven by monoamine reuptake — the pathway SSRIs like sertraline and escitalopram target — but by downstream AMPA receptor potentiation, BDNF release, and rapid synaptogenesis in the prefrontal cortex and hippocampus. Those mechanisms are the reason clinical response emerges in hours to days rather than the four to six weeks a serotonergic antidepressant requires to demonstrate benefit on the PHQ-9 or MADRS.

That temporal advantage is the reason IV ketamine therapy sits where it does in the treatment-resistant depression algorithm. When a patient has failed adequate trials of two or more antidepressants — the standard TRD threshold — and augmentation with aripiprazole, lithium, or quetiapine has been tried or is contraindicated, waiting another six weeks on a fourth medication trial is often not clinically acceptable. In acute suicidality, ketamine’s documented reduction in suicidal ideation within 24 hours shapes crisis-pathway decisions. Ketamine is not a first-line agent; it is the intervention chosen when the timeline of standard pharmacology is not survivable or when that pharmacology has already been exhausted.

The 40-minute infusion, monitored recovery, and six-session induction

Each infusion visit runs roughly two hours end to end. Intake vitals — blood pressure, heart rate, oxygen saturation, respiratory rate — are documented before the IV line is placed. The infusion itself is 0.5 mg/kg racemic ketamine over 40 minutes, weight-adjusted, and occasionally titrated on subsequent sessions based on prior response and tolerability. Vitals are monitored continuously during the infusion, and dissociative symptoms are quantified with the Clinician-Administered Dissociative States Scale (CADSS) at set intervals.

Post-infusion monitoring runs 30 to 60 minutes. The client remains in the recovery suite until dissociation resolves, orthostatic vitals normalize, and gait is stable. Because acute cognitive and motor effects persist for hours, clients are driven home by a designated adult; ride-share is not accepted for discharge. The induction series is six infusions across two to three weeks — the compressed interval is deliberate, since the outcomes literature is clearest on response consolidation inside that window. Stretching induction beyond three weeks correlates with weaker response quality and shorter remission duration.

Integration with psychotherapy makes response durable

Ketamine opens a window; therapy determines whether the client walks through it. RECO’s protocol pairs each infusion with an integration session, typically the following day, during which a masters-level or doctoral therapist works with the affective and cognitive material that surfaced during the dissociative window. Therapeutic frames vary by presentation: ACT for values re-anchoring, cognitive processing therapy or EMDR for trauma content that emerged, MI for motivational shifts around substance use, and cognitive-behavioral techniques for the specific depressive cognitions the client can now examine from a distance.

The published data on ketamine without integration is unambiguous. Response duration is shorter, relapse is more common, and the six-week remission rates that make ketamine attractive in the first place are difficult to sustain. Integration is not an add-on service — it is the reason the ketamine works past the first month.

Ketamine vs Spravato and how we decide

IV racemic ketamine is used off-label for depression and is generally cash-pay. Spravato (esketamine) is FDA-approved for treatment-resistant depression and for major depressive disorder with acute suicidal ideation, delivered intranasally under a REMS protocol, and covered by most commercial insurance including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. The clinical differences are real but narrower than the marketing implies. Both act on the NMDA receptor, both require monitored administration and a driver home, and both work best when integrated with therapy.

The decision is made during the psychiatry consult. Spravato is the right choice when insurance coverage is the deciding financial factor and a twice-weekly-for-four-weeks induction schedule is workable. IV ketamine is the right choice when dose flexibility matters — a client who has not responded to standard Spravato dosing, for example — when a compressed induction is clinically indicated, or when the psychiatrist judges that racemic ketamine’s slightly broader receptor profile is a better fit for the presentation. RECO Health offers both, and the choice is a shared clinical decision, not a menu item.

Who is a candidate for IV ketamine

IV ketamine is considered for adults with treatment-resistant unipolar or bipolar depression — typically defined as inadequate response to two or more antidepressant trials at adequate dose and duration — for major depressive disorder with acute suicidal ideation, and for PTSD refractory to trauma-focused therapy and first-line pharmacology. Candidacy is not a checklist. It is a psychiatric judgment made after review of medication history, treatment response patterns, functional impairment on scales like the WHODAS, and safety data from the Columbia Suicide Severity Rating Scale.

Contraindications and cautions are specific. Uncontrolled hypertension, recent or unstable cardiovascular disease, active substance use disorder without concurrent treatment, active mania, and active psychosis are exclusions. A history of ketamine use disorder is a relative contraindication addressed case by case. Pregnancy is generally an exclusion. Clients on chronic benzodiazepines may experience blunted response and are counseled about a taper plan before induction where clinically appropriate.

What to expect on your first visit

The first appointment is a psychiatric evaluation, not an infusion. A board-certified psychiatrist reviews prior antidepressant trials with attention to dose, duration, and reason for discontinuation — sertraline, escitalopram, bupropion, venlafaxine, and augmentation with aripiprazole, lithium, or quetiapine are the trials typically documented. Contraindications including uncontrolled hypertension, unstable cardiovascular disease, active mania, and active psychosis are screened. The PHQ-9, GAD-7, and Columbia Suicide Severity Rating Scale are administered to establish a baseline.

If ketamine is clinically appropriate, the first infusion is typically scheduled within one to two weeks. Clients receive written pre-infusion instructions — no solid food for four hours prior, clear liquids until two hours prior, current medications reviewed and adjusted as needed, driver confirmed. The therapy team is looped in before infusion one so integration sessions are on the calendar from day one.

Insurance and admissions from Palm Beach Gardens

Admissions handles insurance verification directly. Spravato is billed to Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS under the standard REMS pathway. IV ketamine is generally out-of-pocket, with transparent per-infusion and full-induction pricing provided before the psychiatry consult so the financial picture is clear at the point of clinical decision.

The commute from Palm Beach Gardens is 25 miles south on I-95, roughly 35 minutes off-peak. For PGA National, Mirasol, and BallenIsles residents, that places the psychiatry appointment and first infusion within a single half-day. Same-week evaluations are standard when a partial-hospitalization level of care is not required; when higher acuity is present, admissions coordinates ketamine within a broader treatment plan that may include PHP or IOP concurrently.

Serving residents of: BallenIsles, Frenchman's Reserve, Mirasol, Old Palm, PGA National.